SOX9 and neoplasm: Considering their essentiality to the onset of aberrant stem-like gene expression and subsequent tumor initiation in the colonic epithelium, development-associated factors (e.g., Sox9) are now also proposed as prospective therapeutic targets to block tumorigenesis at the root (Figure 1).